首页 > 最新文献

Journal of Geriatric Cardiology最新文献

英文 中文
Life's essential 8 and risk of subclinical atherosclerosis progression: a prospective cohort study. 生活必需品 8 与亚临床动脉粥样硬化进展风险:一项前瞻性队列研究。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-28 DOI: 10.26599/1671-5411.2024.07.005
Shi-Yu Zhou, Fang-Chao Liu, Shu-Feng Chen, Jian-Xin Li, Jie Cao, Ke-Yong Huang, Zheng-Hao Tang, Feng-Chao Liang, Dong-Sheng Hu, Lian-Cheng Zhao, Ying Li, Jian-Feng Huang, Xiang-Feng Lu, Bin Lu, Dong-Feng Gu

Background: Previous studies have demonstrated the benefits of ideal cardiovascular health (CVH) in reducing cardiovascular risk. However, its role in subclinical atherosclerosis (SA) progression remains unclear. We aim to examine the association of CVH, estimated by the American Heart Association's new Life's Essential 8 (LE8), with the progression of SA.

Methods: This prospective cohort study was conducted among 972 asymptomatic Chinese participants and followed up for 5.7 years. The LE8 score (range, 0-100) consisted of blood pressure, lipids, glucose, body mass index, smoking status, diet health, physical activity and sleep health was evaluated in 1998 and 2008-2009. Progression of SA was determined by carotid plaque and coronary artery calcification (CAC) in 2008-2009 and 2013-2014. Log-binomial regression model was used to estimate the association of LE8 score with SA progression.

Results: Each 10 points increment in LE8 score was associated with 15.2% (RR: 0.848, 95% CI: 0.797-0.902), 17.7% (RR: 0.823, 95% CI: 0.766-0.884) and 12.0% (RR: 0.880, 95% CI: 0.845-0.916) lower risks of carotid plaque, CAC and overall SA progression, respectively. Compared with participants with non-ideal CVH at both visits, the participants with ideal CVH at both visits had 39.1% (RR: 0.609, 95% CI: 0.494-0.752), 41.0% (RR: 0.590, 95% CI: 0.456-0.764) and 29.7% (RR: 0.703, 95% CI: 0.598-0.825) lower risks of carotid plaque, CAC and overall SA progression, respectively.

Conclusions: Higher LE8 scores were associated with lower risks of SA progression. Besides, long-term maintenance of optimal CVH was more beneficial to prevent SA progression.

背景:以往的研究表明,理想的心血管健康(CVH)有利于降低心血管风险。然而,其在亚临床动脉粥样硬化(SA)进展中的作用仍不清楚。我们的目的是研究根据美国心脏协会新的生命基本指标 8(LE8)估算的 CVH 与亚临床动脉粥样硬化进展的关系:这项前瞻性队列研究对 972 名无症状的中国参与者进行了为期 5.7 年的随访。1998年和2008-2009年的LE8评分(范围0-100)包括血压、血脂、血糖、体重指数、吸烟状况、饮食健康、体力活动和睡眠健康。2008-2009年和2013-2014年,通过颈动脉斑块和冠状动脉钙化(CAC)确定了SA的进展情况。采用对数二叉回归模型估计LE8评分与SA进展的关系:LE8得分每增加10分,颈动脉斑块、CAC和整体SA恶化的风险分别降低15.2%(RR:0.848,95% CI:0.797-0.902)、17.7%(RR:0.823,95% CI:0.766-0.884)和12.0%(RR:0.880,95% CI:0.845-0.916)。与两次检查均为非理想CVH的参与者相比,两次检查均为理想CVH的参与者颈动脉斑块、CAC和总体SA进展的风险分别降低了39.1%(RR:0.609,95% CI:0.494-0.752)、41.0%(RR:0.590,95% CI:0.456-0.764)和29.7%(RR:0.703,95% CI:0.598-0.825):结论:LE8评分越高,SA恶化的风险越低。结论:LE8评分越高,SA进展的风险越低。此外,长期保持最佳CVH更有利于预防SA进展。
{"title":"Life's essential 8 and risk of subclinical atherosclerosis progression: a prospective cohort study.","authors":"Shi-Yu Zhou, Fang-Chao Liu, Shu-Feng Chen, Jian-Xin Li, Jie Cao, Ke-Yong Huang, Zheng-Hao Tang, Feng-Chao Liang, Dong-Sheng Hu, Lian-Cheng Zhao, Ying Li, Jian-Feng Huang, Xiang-Feng Lu, Bin Lu, Dong-Feng Gu","doi":"10.26599/1671-5411.2024.07.005","DOIUrl":"10.26599/1671-5411.2024.07.005","url":null,"abstract":"<p><strong>Background: </strong>Previous studies have demonstrated the benefits of ideal cardiovascular health (CVH) in reducing cardiovascular risk. However, its role in subclinical atherosclerosis (SA) progression remains unclear. We aim to examine the association of CVH, estimated by the American Heart Association's new Life's Essential 8 (LE8), with the progression of SA.</p><p><strong>Methods: </strong>This prospective cohort study was conducted among 972 asymptomatic Chinese participants and followed up for 5.7 years. The LE8 score (range, 0-100) consisted of blood pressure, lipids, glucose, body mass index, smoking status, diet health, physical activity and sleep health was evaluated in 1998 and 2008-2009. Progression of SA was determined by carotid plaque and coronary artery calcification (CAC) in 2008-2009 and 2013-2014. Log-binomial regression model was used to estimate the association of LE8 score with SA progression.</p><p><strong>Results: </strong>Each 10 points increment in LE8 score was associated with 15.2% (RR: 0.848, 95% CI: 0.797-0.902), 17.7% (RR: 0.823, 95% CI: 0.766-0.884) and 12.0% (RR: 0.880, 95% CI: 0.845-0.916) lower risks of carotid plaque, CAC and overall SA progression, respectively. Compared with participants with non-ideal CVH at both visits, the participants with ideal CVH at both visits had 39.1% (RR: 0.609, 95% CI: 0.494-0.752), 41.0% (RR: 0.590, 95% CI: 0.456-0.764) and 29.7% (RR: 0.703, 95% CI: 0.598-0.825) lower risks of carotid plaque, CAC and overall SA progression, respectively.</p><p><strong>Conclusions: </strong>Higher LE8 scores were associated with lower risks of SA progression. Besides, long-term maintenance of optimal CVH was more beneficial to prevent SA progression.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 7","pages":"751-759"},"PeriodicalIF":1.8,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11341528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpretation of Chinese Expert Consensus on the Diagnosis and Management Strategy of Patients with Statin Intolerance: A guiding file for helping to lipid management for Chinese population. 他汀类药物不耐受患者诊断和管理策略中国专家共识》解读:帮助中国人群进行血脂管理的指导文件。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-28 DOI: 10.26599/1671-5411.2024.07.006
Jian-Jun Li

It is well-known that elevated low-density lipoprotein cholesterol (LDL-C) is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD), statins are cornerstone drugs for the cause-based treatment of ASCVD, which has created a new era for ASCVD therapy. However, statin intolerance is not clinically uncommon, which there are several issues with confusion and misunderstandings. Hence, a file named Chinese Expert Consensus on the Diagnosis and Management Strategy of Patients With Statin Intolerance, like a navigator, has recently been published written by a team of experts from the Cardiovascular Metabolic Medicine Professional Committee, Expert Committee of the National Center for Cardiovascular Diseases aiming to enhance the standardized clinical application of statins and improve the prevention and clinical outcome. In this article, author briefly summarized the key points of above consensus in order to helping to comprehending the content of the consensus suggestions.

众所周知,低密度脂蛋白胆固醇(LDL-C)升高是动脉粥样硬化性心血管疾病(ASCVD)的病因性危险因素,他汀类药物是基于病因治疗 ASCVD 的基石药物,开创了 ASCVD 治疗的新纪元。然而,他汀类药物不耐受在临床上并不少见,其中存在着一些困惑和误区。因此,由国家心血管病中心专家委员会心血管代谢医学专业委员会专家团队撰写的《他汀类药物不耐受患者诊治策略中国专家共识》文件近日出版,该文件犹如导航仪,旨在加强他汀类药物的规范化临床应用,提高预防和临床疗效。本文作者简要总结了上述共识的要点,以帮助理解共识建议的内容。
{"title":"Interpretation of Chinese Expert Consensus on the Diagnosis and Management Strategy of Patients with Statin Intolerance: A guiding file for helping to lipid management for Chinese population.","authors":"Jian-Jun Li","doi":"10.26599/1671-5411.2024.07.006","DOIUrl":"10.26599/1671-5411.2024.07.006","url":null,"abstract":"<p><p>It is well-known that elevated low-density lipoprotein cholesterol (LDL-C) is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD), statins are cornerstone drugs for the cause-based treatment of ASCVD, which has created a new era for ASCVD therapy. However, statin intolerance is not clinically uncommon, which there are several issues with confusion and misunderstandings. Hence, a file named Chinese Expert Consensus on the Diagnosis and Management Strategy of Patients With Statin Intolerance, like a navigator, has recently been published written by a team of experts from the Cardiovascular Metabolic Medicine Professional Committee, Expert Committee of the National Center for Cardiovascular Diseases aiming to enhance the standardized clinical application of statins and improve the prevention and clinical outcome. In this article, author briefly summarized the key points of above consensus in order to helping to comprehending the content of the consensus suggestions.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 7","pages":"713-715"},"PeriodicalIF":1.8,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11341533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of being in the COVID-19 pandemic on in-hospital mortality of non-infected patients aged 80 years and older with ST-elevation myocardial ınfarction. COVID-19大流行对80岁及以上ST段抬高型心肌梗死非感染者院内死亡率的影响。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-28 DOI: 10.26599/1671-5411.2024.07.008
Mustafa Ebik, Muhammet Gürdoğan, Uğur Özkan
{"title":"The impact of being in the COVID-19 pandemic on in-hospital mortality of non-infected patients aged 80 years and older with ST-elevation myocardial ınfarction.","authors":"Mustafa Ebik, Muhammet Gürdoğan, Uğur Özkan","doi":"10.26599/1671-5411.2024.07.008","DOIUrl":"10.26599/1671-5411.2024.07.008","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 7","pages":"768-774"},"PeriodicalIF":1.8,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11341530/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to manage the malposition of deep vein catheterization into the artery? 如何处理深静脉导管插入动脉的位置不当?
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-28 DOI: 10.26599/1671-5411.2024.06.007
Jun-Na Sun, Hai Dong, Peng Chen, Zi-Qi Li, Li-You Sui, Bin Qi, Quan-Min Jing
{"title":"How to manage the malposition of deep vein catheterization into the artery?","authors":"Jun-Na Sun, Hai Dong, Peng Chen, Zi-Qi Li, Li-You Sui, Bin Qi, Quan-Min Jing","doi":"10.26599/1671-5411.2024.06.007","DOIUrl":"10.26599/1671-5411.2024.06.007","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 6","pages":"682-685"},"PeriodicalIF":1.8,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224658/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged asystole following adenosine. Was it necessary? 使用腺苷后出现的长时间心搏骤停。有必要使用吗?
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-28 DOI: 10.26599/1671-5411.2024.06.005
Yuval Avidan, Amir Aker, Vsevolod Tabachnikov
{"title":"Prolonged asystole following adenosine. Was it necessary?","authors":"Yuval Avidan, Amir Aker, Vsevolod Tabachnikov","doi":"10.26599/1671-5411.2024.06.005","DOIUrl":"10.26599/1671-5411.2024.06.005","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 6","pages":"686-688"},"PeriodicalIF":1.8,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between stress hyperglycemia ratio and in-hospital outcomes: findings from the improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project. 应激性高血糖比率与院内预后之间的关系:改善中国心血管疾病护理--急性冠脉综合征(CCC-ACS)项目的研究结果。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-28 DOI: 10.26599/1671-5411.2024.06.006
Wen-Jie Wang, Ke-Xin Wang, Jia-Long Niu, Yi-Xuan Liu, Hai-Long Ge, Hua Shen

Background: Stress hyperglycemia ratio (SHR) could provide accurate information on the acute status of hyperglycemia. The relationship between SHR and acute coronary syndrome (ACS) prognosis remains unclear. This study was conducted to identity the association between SHR and in-hospital outcomes in patients with ACS.

Methods: A total of 12,010 patients were eventually enrolled in the study. The relationship between SHR and in-hospital major adverse cardiovascular events (MACEs) was then modeled by restricted cubic spline (RCS) curves, and all patients were divided into three groups according to the results. The multivariate logistic regression analysis was used to determine the associations between the SHR and in-hospital outcomes, described as odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analyses were also performed on different diseases.

Results: The median age of this cohort was 63 (54, 71) years old, and 8942 (74.5%) were male. Group 1 was defined as SHR < 0.6 (n = 426), Group 2 was defined as SHR between 0.6 and 1 (n = 5821), and Group 3 was defined as SHR > 1 (n = 5763). Compared with Group 2, Group 1 (OR = 1.891, 95% CI: 1.028-3.479, P < 0.001) and Group 3 (OR = 1.868, 95% CI: 1.434-2.434, P < 0.001) had higher risks of suffering from in-hospital MACEs. SHR was associated with higher risks of in-hospital MACEs in the subgroups of DM [OR = 2.282, 95% CI: 1.477-3.524).

Conclusions: Both low and high SHR levels were independently associated with in-hospital MACEs. Young males with DM, hypertension, and decreased renal function had much higher risks of suffering from SHR-correlated MACEs.

背景:应激性高血糖比值(SHR)可提供有关高血糖急性状态的准确信息。但 SHR 与急性冠状动脉综合征(ACS)预后的关系仍不明确。本研究旨在确定 SHR 与急性冠状动脉综合征患者院内预后之间的关系:最终共有 12010 名患者参与了研究。方法:研究最终共纳入了 12010 名患者,然后通过限制性三次样条曲线(RCS)建立了 SHR 与院内主要不良心血管事件(MACE)之间的关系模型,并根据结果将所有患者分为三组。多变量逻辑回归分析用于确定SHR与院内预后之间的关系,以几率比(OR)和95%置信区间(CI)表示。此外,还对不同疾病进行了分组分析:队列的中位年龄为 63(54,71)岁,8942 人(74.5%)为男性。第 1 组定义为 SHR < 0.6(426 人),第 2 组定义为 SHR 介于 0.6 和 1 之间(5821 人),第 3 组定义为 SHR > 1(5763 人)。与第 2 组相比,第 1 组(OR = 1.891,95% CI:1.028-3.479,P <0.001)和第 3 组(OR = 1.868,95% CI:1.434-2.434,P <0.001)发生院内 MACE 的风险更高。在DM亚组中,SHR与较高的院内MACE风险相关[OR = 2.282, 95% CI: 1.477-3.524]:结论:低和高SHR水平均与院内MACEs独立相关。患有糖尿病、高血压和肾功能减退的年轻男性发生 SHR 相关并发症的风险更高。
{"title":"Association between stress hyperglycemia ratio and in-hospital outcomes: findings from the improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project.","authors":"Wen-Jie Wang, Ke-Xin Wang, Jia-Long Niu, Yi-Xuan Liu, Hai-Long Ge, Hua Shen","doi":"10.26599/1671-5411.2024.06.006","DOIUrl":"10.26599/1671-5411.2024.06.006","url":null,"abstract":"<p><strong>Background: </strong>Stress hyperglycemia ratio (SHR) could provide accurate information on the acute status of hyperglycemia. The relationship between SHR and acute coronary syndrome (ACS) prognosis remains unclear. This study was conducted to identity the association between SHR and in-hospital outcomes in patients with ACS.</p><p><strong>Methods: </strong>A total of 12,010 patients were eventually enrolled in the study. The relationship between SHR and in-hospital major adverse cardiovascular events (MACEs) was then modeled by restricted cubic spline (RCS) curves, and all patients were divided into three groups according to the results. The multivariate logistic regression analysis was used to determine the associations between the SHR and in-hospital outcomes, described as odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analyses were also performed on different diseases.</p><p><strong>Results: </strong>The median age of this cohort was 63 (54, 71) years old, and 8942 (74.5%) were male. Group 1 was defined as SHR < 0.6 (<i>n</i> = 426), Group 2 was defined as SHR between 0.6 and 1 (<i>n</i> = 5821), and Group 3 was defined as SHR > 1 (<i>n</i> = 5763). Compared with Group 2, Group 1 (OR = 1.891, 95% CI: 1.028-3.479, <i>P</i> < 0.001) and Group 3 (OR = 1.868, 95% CI: 1.434-2.434, <i>P</i> < 0.001) had higher risks of suffering from in-hospital MACEs. SHR was associated with higher risks of in-hospital MACEs in the subgroups of DM [OR = 2.282, 95% CI: 1.477-3.524).</p><p><strong>Conclusions: </strong>Both low and high SHR levels were independently associated with in-hospital MACEs. Young males with DM, hypertension, and decreased renal function had much higher risks of suffering from SHR-correlated MACEs.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 6","pages":"658-668"},"PeriodicalIF":1.8,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart failure in China: epidemiology and current management. 中国的心力衰竭:流行病学和管理现状。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-28 DOI: 10.26599/1671-5411.2024.06.008
Sheng-Shou Hu

The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this sixth section of the report offers a comprehensive analysis of heart failure (HF) in China. HF is one of the most important cardiovascular disease in the 21st century. Its mortality is equivalent to that of cancer. It is an important public health problem that seriously affects the health of Chinese residents. In recent years, with the deepening of understanding, the change of treatment principles, the innovation of treatment methods and the update of treatment guidelines, the in-hospital mortality of HF patients has declined, and the long-term prognosis is also improving. However, there are still differences in the management level of HF among different hospitals in China. How to improve the standardized diagnosis and treatment level of HF in China remains an important challenge.

中国心血管健康与疾病年度报告(2022)》对中国心血管健康状况进行了深入分析。本报告的第六部分将结合上一部分,对中国心力衰竭(HF)进行全面分析。心力衰竭是 21 世纪最重要的心血管疾病之一。其死亡率与癌症相当。它是严重影响中国居民健康的重要公共卫生问题。近年来,随着认识的深化、治疗原则的改变、治疗方法的创新和治疗指南的更新,高血压患者的院内死亡率有所下降,远期预后也在改善。然而,我国不同医院对心房颤动的管理水平仍存在差异。如何提高中国心房颤动的规范化诊治水平仍是一项重要挑战。
{"title":"Heart failure in China: epidemiology and current management.","authors":"Sheng-Shou Hu","doi":"10.26599/1671-5411.2024.06.008","DOIUrl":"10.26599/1671-5411.2024.06.008","url":null,"abstract":"<p><p>The <i>Annual Report on Cardiovascular Health and Diseases in China</i> (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this sixth section of the report offers a comprehensive analysis of heart failure (HF) in China. HF is one of the most important cardiovascular disease in the 21<sup>st</sup> century. Its mortality is equivalent to that of cancer. It is an important public health problem that seriously affects the health of Chinese residents. In recent years, with the deepening of understanding, the change of treatment principles, the innovation of treatment methods and the update of treatment guidelines, the in-hospital mortality of HF patients has declined, and the long-term prognosis is also improving. However, there are still differences in the management level of HF among different hospitals in China. How to improve the standardized diagnosis and treatment level of HF in China remains an important challenge.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 6","pages":"631-641"},"PeriodicalIF":1.8,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2023 Guideline for the management of hypertension in the elderly population in China. 2023 中国老年人群高血压管理指南。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-28 DOI: 10.26599/1671-5411.2024.06.001
Qi Hua, Li Fan, Zeng-Wu Wang, Jing Li
{"title":"2023 Guideline for the management of hypertension in the elderly population in China.","authors":"Qi Hua, Li Fan, Zeng-Wu Wang, Jing Li","doi":"10.26599/1671-5411.2024.06.001","DOIUrl":"10.26599/1671-5411.2024.06.001","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 6","pages":"589-630"},"PeriodicalIF":1.8,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary cooking oils and cardiometabolic measurements in an elderly Chinese population. 中国老年人口中的膳食食用油和心脏代谢测量结果。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-28 DOI: 10.26599/1671-5411.2024.06.002
Xin-Yu Wang, Chao-Ying Miao, Xiao-Fei Ye, Wen-Yuan-Yue Wang, Jia-Bo Zhu, Yi Zhou, Yan Li, Ji-Guang Wang

Objective: To investigate three features of dietary cooking oil intake, namely, the consumption, cooking style, and composition of fatty acids in relation to several cardiometabolic measurements in an elderly Chinese population.

Methods: The elderly (≥ 65 years) participants for this study were recruited from two community health centers in the urban area of Shanghai. A questionnaire was administered to collect information on dietary oil consumption (low, medium and high) and cooking styles (fry or stir-fry vs. others) and the composition of fatty acids (poly-unsaturated vs. mono-unsaturated). The cardiometabolic measurements included anthropometry, blood pressure, fasting plasma glucose and serum lipids.

Results: The 1186 study participants had a mean age of 70.9 ± 5.4 years. The mean dietary oil consumption was 35.0 g/d, being low (< 25 g/d), medium (25-49 g/d) and high (≥ 50 g/d) in 485,467 and 234 participants, respectively. The proportion of the fry or stir-fry cooking style and oils rich in mono-unsaturated fatty acids was 30.4% and 27.4%, respectively. Both before and after adjustment for sex, age, current smoking and alcohol intake, dietary oil consumption was significantly (P ≤ 0.02) and positively associated with the prevalence of treated hypertension and fasting plasma glucose concentration. With similar adjustments as above and additional adjustment for dietary oil consumption, the fry or stir-fry cooking style was significantly (P ≤ 0.048) and positively associated with body mass index, but inversely with systolic and diastolic blood pressure and serum low-density lipoprotein cholesterol, and the dietary intake of oils rich in mono-unsaturated fat acids was significantly (P ≤ 0.02) and positively associated with diastolic blood pressure, serum triglycerides, total cholesterol and low-density lipoprotein cholesterol, and the prevalence of hypertriglyceridemia and hypercholesterolemia.

Conclusions: This study showed that both the consumption and composition of fatty acids of the dietary oils mattered with regard to several cardiometabolic measurements in an elderly Chinese population.

目的调查中国老年人膳食中食用油摄入的三个特征,即食用量、烹饪方式和脂肪酸组成与几项心脏代谢测量指标的关系:本研究的老年参与者(≥ 65 岁)来自上海城区的两个社区卫生服务中心。通过问卷调查收集了有关膳食用油量(低、中、高)、烹饪方式(煎、炒与其他)以及脂肪酸组成(多不饱和与单不饱和)的信息。心脏代谢测量包括人体测量、血压、空腹血浆葡萄糖和血脂:1186 名研究参与者的平均年龄为 70.9 ± 5.4 岁。平均膳食油摄入量为 35.0 克/天,低(< 25 克/天)、中(25-49 克/天)和高(≥ 50 克/天)膳食油摄入量分别为 485、467 和 234 人。煎、炒烹饪方式和富含单不饱和脂肪酸油类的比例分别为 30.4% 和 27.4%。在对性别、年龄、目前吸烟和饮酒情况进行调整之前和调整之后,膳食油的摄入量与接受治疗的高血压患病率和空腹血浆葡萄糖浓度均呈显著正相关(P ≤ 0.02)。经上述类似调整并对膳食油消耗量进行额外调整后,煎或炒的烹饪方式与体重指数呈显著正相关(P ≤ 0.048),但与收缩压和舒张压以及血清低密度脂蛋白胆固醇呈反相关;富含单不饱和脂肪酸的膳食油摄入量与舒张压和血清低密度脂蛋白胆固醇呈显著正相关(P ≤ 0.02),与舒张压、血清甘油三酯、总胆固醇和低密度脂蛋白胆固醇以及高甘油三酯血症和高胆固醇血症的患病率呈正相关:这项研究表明,在中国老年人群中,膳食油脂肪酸的摄入量和组成与多项心血管代谢指标有关。
{"title":"Dietary cooking oils and cardiometabolic measurements in an elderly Chinese population.","authors":"Xin-Yu Wang, Chao-Ying Miao, Xiao-Fei Ye, Wen-Yuan-Yue Wang, Jia-Bo Zhu, Yi Zhou, Yan Li, Ji-Guang Wang","doi":"10.26599/1671-5411.2024.06.002","DOIUrl":"10.26599/1671-5411.2024.06.002","url":null,"abstract":"<p><strong>Objective: </strong>To investigate three features of dietary cooking oil intake, namely, the consumption, cooking style, and composition of fatty acids in relation to several cardiometabolic measurements in an elderly Chinese population.</p><p><strong>Methods: </strong>The elderly (≥ 65 years) participants for this study were recruited from two community health centers in the urban area of Shanghai. A questionnaire was administered to collect information on dietary oil consumption (low, medium and high) and cooking styles (fry or stir-fry <i>vs.</i> others) and the composition of fatty acids (poly-unsaturated <i>vs.</i> mono-unsaturated). The cardiometabolic measurements included anthropometry, blood pressure, fasting plasma glucose and serum lipids.</p><p><strong>Results: </strong>The 1186 study participants had a mean age of 70.9 ± 5.4 years. The mean dietary oil consumption was 35.0 g/d, being low (< 25 g/d), medium (25-49 g/d) and high (≥ 50 g/d) in 485,467 and 234 participants, respectively. The proportion of the fry or stir-fry cooking style and oils rich in mono-unsaturated fatty acids was 30.4% and 27.4%, respectively. Both before and after adjustment for sex, age, current smoking and alcohol intake, dietary oil consumption was significantly (<i>P</i> ≤ 0.02) and positively associated with the prevalence of treated hypertension and fasting plasma glucose concentration. With similar adjustments as above and additional adjustment for dietary oil consumption, the fry or stir-fry cooking style was significantly (<i>P</i> ≤ 0.048) and positively associated with body mass index, but inversely with systolic and diastolic blood pressure and serum low-density lipoprotein cholesterol, and the dietary intake of oils rich in mono-unsaturated fat acids was significantly (<i>P</i> ≤ 0.02) and positively associated with diastolic blood pressure, serum triglycerides, total cholesterol and low-density lipoprotein cholesterol, and the prevalence of hypertriglyceridemia and hypercholesterolemia.</p><p><strong>Conclusions: </strong>This study showed that both the consumption and composition of fatty acids of the dietary oils mattered with regard to several cardiometabolic measurements in an elderly Chinese population.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 6","pages":"642-650"},"PeriodicalIF":1.8,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of cardioneuroablation in different subtypes of vasovagal syncope. 对不同亚型的血管迷走性晕厥进行心脏神经消融术的效果。
IF 1.8 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-28 DOI: 10.26599/1671-5411.2024.06.004
Bin Tu, Zi-Hao Lai, Ai-Yue Chen, Zhi-Yuan Weng, Si-Min Cai, Zhu-Xin Zhang, Li-Kun Zhou, Li-Hui Zheng, Yan Yao

Background: Cardioneuroablation (CNA) has shown encouraging results in patients with vasovagal syncope (VVS). However, data on different subtypes was scarce.

Methods: This observational study retrospectively enrolled 141 patients [mean age: 40 ± 18 years, 51 males (36.2%)] with the diagnosis of VVS. The characteristics among different types of VVS and the outcomes after CNA were analyzed.

Results: After a mean follow-up of 4.3 ± 1.5 years, 41 patients (29.1%) experienced syncope/pre-syncope events after CNA. Syncope/pre-syncope recurrence significantly differed in each subtype (P = 0.04). The cardioinhibitory type of VVS had the lowest recurrence rate after the procedure (n = 6, 16.7%), followed by mixed (n = 26, 30.6%) and vasodepressive (n = 9, 45.0%). Additionally, a significant difference was observed in the analyses of the Kaplan-Meier survival curve (P = 0.02). Syncope/pre-syncope burden was significantly reduced after CNA in the vasodepressive type (P < 0.01). Vasodepressive types with recurrent syncope/pre-syncope after CNA have a lower baseline deceleration capacity (DC) level than those without (7.4 ± 1.0 ms vs. 9.0 ± 1.6 ms, P = 0.01). Patients with DC < 8.4 ms had an 8.1 (HR = 8.1, 95% CI: 2.2-30.0, P = 0.02) times risk of syncope/pre-syncope recurrence after CNA compared to patients with DC ≥ 8.4 ms, and this association still existed after adjusting for age and sex (HR = 8.1, 95% CI: 2.2-30.1, P = 0.02).

Conclusions: Different subtypes exhibit different event-free rates. The vasodepressive type exhibited the lowest event-free rate, but those patients with DC ≥ 8.4 ms might benefit from CNA.

背景:心脏血管神经消融术(CNA)在血管迷走性晕厥(VVS)患者中取得了令人鼓舞的效果。然而,有关不同亚型的数据却很少:这项观察性研究回顾性地纳入了 141 名被诊断为 VVS 的患者[平均年龄:40 ± 18 岁,51 名男性(36.2%)]。分析了不同类型 VVS 的特征以及 CNA 后的结果:平均随访 4.3 ± 1.5 年后,41 名患者(29.1%)在 CNA 后出现晕厥/晕厥前事件。每个亚型的晕厥/晕厥前症状复发率均有显著差异(P = 0.04)。心抑制型 VVS 术后复发率最低(6 人,16.7%),其次是混合型(26 人,30.6%)和血管抑制型(9 人,45.0%)。此外,Kaplan-Meier 生存曲线分析也发现了明显差异(P = 0.02)。血管抑郁型患者在接受 CNA 治疗后,晕厥/晕厥前负担明显减轻(P < 0.01)。CNA 后复发晕厥/晕厥前症的血管抑郁型患者的基线减速能力(DC)水平低于非血管抑郁型患者(7.4 ± 1.0 ms vs. 9.0 ± 1.6 ms,P = 0.01)。DC<8.4毫秒的患者与DC≥8.4毫秒的患者相比,CNA后晕厥/晕厥前症状复发的风险是后者的8.1倍(HR = 8.1,95% CI:2.2-30.0,P = 0.02),调整年龄和性别后,这种关联仍然存在(HR = 8.1,95% CI:2.2-30.1,P = 0.02):不同亚型表现出不同的无事件发生率。血管抑郁型的无事件发生率最低,但 DC≥8.4 ms 的患者可能会从 CNA 中获益。
{"title":"Effectiveness of cardioneuroablation in different subtypes of vasovagal syncope.","authors":"Bin Tu, Zi-Hao Lai, Ai-Yue Chen, Zhi-Yuan Weng, Si-Min Cai, Zhu-Xin Zhang, Li-Kun Zhou, Li-Hui Zheng, Yan Yao","doi":"10.26599/1671-5411.2024.06.004","DOIUrl":"10.26599/1671-5411.2024.06.004","url":null,"abstract":"<p><strong>Background: </strong>Cardioneuroablation (CNA) has shown encouraging results in patients with vasovagal syncope (VVS). However, data on different subtypes was scarce.</p><p><strong>Methods: </strong>This observational study retrospectively enrolled 141 patients [mean age: 40 ± 18 years, 51 males (36.2%)] with the diagnosis of VVS. The characteristics among different types of VVS and the outcomes after CNA were analyzed.</p><p><strong>Results: </strong>After a mean follow-up of 4.3 ± 1.5 years, 41 patients (29.1%) experienced syncope/pre-syncope events after CNA. Syncope/pre-syncope recurrence significantly differed in each subtype (<i>P</i> = 0.04). The cardioinhibitory type of VVS had the lowest recurrence rate after the procedure (<i>n</i> = 6, 16.7%), followed by mixed (<i>n</i> = 26, 30.6%) and vasodepressive (<i>n</i> = 9, 45.0%). Additionally, a significant difference was observed in the analyses of the Kaplan-Meier survival curve (<i>P</i> = 0.02). Syncope/pre-syncope burden was significantly reduced after CNA in the vasodepressive type (<i>P</i> < 0.01). Vasodepressive types with recurrent syncope/pre-syncope after CNA have a lower baseline deceleration capacity (DC) level than those without (7.4 ± 1.0 ms <i>vs.</i> 9.0 ± 1.6 ms, <i>P</i> = 0.01). Patients with DC < 8.4 ms had an 8.1 (HR = 8.1, 95% CI: 2.2-30.0, <i>P</i> = 0.02) times risk of syncope/pre-syncope recurrence after CNA compared to patients with DC ≥ 8.4 ms, and this association still existed after adjusting for age and sex (HR = 8.1, 95% CI: 2.2-30.1, <i>P</i> = 0.02).</p><p><strong>Conclusions: </strong>Different subtypes exhibit different event-free rates. The vasodepressive type exhibited the lowest event-free rate, but those patients with DC ≥ 8.4 ms might benefit from CNA.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 6","pages":"651-657"},"PeriodicalIF":1.8,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141555864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Geriatric Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1